Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis

Saadeh, 2000, The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis, Cleve Clin J Med, 67, 96, 10.3949/ccjm.67.2.96 Neuschwander–Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193 Bacon, 1994, Nonalcoholic steatohepatitis: an expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6 Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775 Bugianesi, 2002, Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168 White, 2012, Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review, Clin Gastroenterol Hepatol, 10, 1342, 10.1016/j.cgh.2012.10.001 Torres, 2012, Features, diagnosis, and treatment of nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 10, 837, 10.1016/j.cgh.2012.03.011 Koehler, 2009, Fatty liver and liver transplantation, Clin Liver Dis, 13, 621, 10.1016/j.cld.2009.07.010 Charlton, 2011, Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States, Gastroenterology, 141, 1249, 10.1053/j.gastro.2011.06.061 Park, 2011, Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more, Clin Transplant, 25, E606, 10.1111/j.1399-0012.2011.01497.x Vanwagner, 2012, Patients transplanted for nonalcoholic steatohepatitis (NASH) are at increased risk for post–operative cardiovascular events, Hepatology, 56, 1741, 10.1002/hep.25855 Houlihan, 2011, Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?, Liver Transpl, 17, 1292, 10.1002/lt.22382 Reddy, 2012, Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease, Hepatology, 55, 1809, 10.1002/hep.25536 Kennedy, 2012, Equivalent survival following liver transplantation in patients with non–alcoholic steatohepatitis compared with patients with other liver diseases, HPB (Oxford), 14, 625, 10.1111/j.1477-2574.2012.00497.x Bhagat, 2009, Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease, Liver Transpl, 15, 1814, 10.1002/lt.21927 Barritt, 2011, The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes, J Clin Gastroenterol, 45, 372, 10.1097/MCG.0b013e3181eeaff0 Malik, 2009, Outcome after liver transplantation for NASH cirrhosis, Am J Transplant, 9, 782, 10.1111/j.1600-6143.2009.02590.x Agopian, 2012, Liver transplantation for nonalcoholic steatohepatitis: the new epidemic, Ann Surg, 256, 624, 10.1097/SLA.0b013e31826b4b7e Afzali, 2012, Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States, Liver Transpl, 18, 29, 10.1002/lt.22435 Wells G, Shea B, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta–analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Demets, 1987, Methods for combining randomized clinical trials: strengths and limitations, Stat Med, 6, 341, 10.1002/sim.4780060325 DerSimonian, 1986, Meta–analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Higgins, 2002, Quantifying heterogeneity in a meta–analysis, Stat Med, 21, 1539, 10.1002/sim.1186 Egger, 1997, Bias in meta–analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta–analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ, 339, b2700, 10.1136/bmj.b2700 Kanwal, 2012, Systematic reviews and meta–analyses, Clin Gastroenterol Hepatol, 10, 1184, 10.1016/j.cgh.2012.09.019 Cohen, 1960, Coefficient of agreement for nominal scales, Educ Psychol Measure, 20, 37, 10.1177/001316446002000104 Therapondos, 2004, Cardiac morbidity and mortality related to orthotopic liver transplantation, Liver Transpl, 10, 1441, 10.1002/lt.20298 Picardi, 2008, Association between non–alcoholic fatty liver disease and cardiovascular disease: a first message should pass, Am J Gastroenterol, 103, 3036, 10.1111/j.1572-0241.2008.02196.x Targher, 2007, Non–alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens, Diabet Med, 24, 1, 10.1111/j.1464-5491.2007.02025.x Bhatia, 2012, Nonalcoholic fatty liver disease and vascular risk, Curr Opin Cardiol, 27, 420, 10.1097/HCO.0b013e328354829c Wade, 1995, Bacterial and fungal infections after liver transplantation: an analysis of 284 patients, Hepatology, 21, 1328, 10.1002/hep.1840210517 Al–Hasan, 2009, Incidence rate and outcome of gram–negative bloodstream infection in solid organ transplant recipients, Am J Transplant, 9, 835, 10.1111/j.1600-6143.2009.02559.x Caldwell, 1999, Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease, Hepatology, 29, 664, 10.1002/hep.510290347 Clark, 2003, Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis, JAMA, 289, 3000, 10.1001/jama.289.22.3000 Struben, 2000, Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds, Am J Med, 108, 9